Grace Potter


Grace Potter the Nocturnals "Paris (Ooh La La) Medicine" - Manchester Ritz 16th March 2013
Grace Potter the Nocturnals supporting The Avett Brothers in the UK.

By: yankeejim33

The rest is here:

Grace Potter

How to Bill an Office Visit with Urinalysis for Internal Medicine Physician – Video


How to Bill an Office Visit with Urinalysis for Internal Medicine Physician
Office Visit with Urinalysis Medical Claim for a Physician Our CPT (Common Procedural Terminology) code for this claim is 99214. This code establishes an off...

By: freemedicalbilling

See the original post:

How to Bill an Office Visit with Urinalysis for Internal Medicine Physician - Video

IOM Looks at the Economics of Genomic Medicine

The Institute of Medicine has released the summary of a workshop it hosted last July to discuss the economic issues likely to arise in the age of genomic medicine.

The workshop brought together economists, regulators, payors, researchers, patients, and other stakeholders to discuss various economic factors likely to influence the integration of genomic data into healthcare.

IOM notes in the report that the workshop was one of a series that it hosted on genomic medicine, "but it was the first focused specifically on economic issues."

The 109-page report outlines "major themes" of the workshop, based on a presentation by Gregory Feero, who was special advisor to the director of the National Human Genome Research Institute at the time.

Specific economic issues can vary by application and by setting, according to Feero's summary. Therefore, "improved methods are needed for assessing value, personal utility, and patient preferences," the report states.

In addition, public health, clinical care, and academic medicine "have different economic assessment models," which "have to be aligned in a way that makes a difference to patients," the report notes.

Other considerations include the need for better and quicker approaches to perform economic evaluations of genetic and genomic tests since evaluating tests and variants one by one "will be too daunting."

Feero also recommended that economic analyses be integrated into all ongoing whole-genome sequencing clinical studies, and noted that "the economic incentives for test and evidence development under the current system of reimbursement versus a value-based pricing approach that incorporates the intellectual cost of interpretation need to be further explored."

See the article here:

IOM Looks at the Economics of Genomic Medicine

Medicine hitches ride to Africa in Coca-Cola crates

10 Kit Yamoyos fit into one crate of Coca-Cola and make use of the unused space between the necks of the bottles.ColaLife/Simon Berry

Coca-Cola is teaming up with the non-profit ColaLife to help better distribute much needed medicine along with Coca-Cola beverages to developing countries.

Beginning as an online movement in 2008, ColaLife became its own independent non-profit in 2011.

According to the non-profits website, Coke products are available almost everywhere in developing nations. However, nearly 1 in 9 children in these countries die before the age of 5 from easily preventable diseases, such as dehydration from diarrhea.

Utilizing a new packaging technique, ColaLife aims to distribute social products, such as oral rehydration salts and zinc supplements, to help sick children in need of medication. The medication will be packaged in newly developed AidPods, which are wedge-shaped to fit in-between the necks of the Coke bottles in a crate of Coca-Cola. The AidPods carry supplies to combat dehydration, as well as micro-nutrients. The package itself doubles as a water sterilization container when emptied.

Over the last three decades, child mortality figures in these developing countries have not changed. The team behind ColaLife hopes its initiative will start to make a difference in these areas of the world.

ColaLifes first pilot plan will operate out of Zambia, Africa, and is called the ColaLife Operational Trial Zambia (COTZ). The distribution kits will be delivered to retailers in the crates and will cost roughly 5,000 kwacha or just $1. Retailers are expected to make a 35 percent profit on the sale of the AidPods, while wholesalers will make a 20 percent profit.

If its trial run is successful, ColaLife hopes to expand its initiative on a much more global scale.

Click for more from ColaLife.

View original post here:

Medicine hitches ride to Africa in Coca-Cola crates

Entrepreneur Works With Coke’s Distribution to Deliver Medicine to Remote African Villages

You would be hard-pressed to travel anywhere in the world and not be able to buy a Coca-Cola. Sadly, the same cannot be said for access to clean water and vital medicine. One man is doing what he can to change that, using the distribution power of large corporations.

In the 1980s, entrepreneur Simon Barry was an aid worker in remote villages in Zambia, and he became aware of how easy it was to grab a Coke nearly every place he went, but he also noticed how many basic necessities were missing. Barry got the idea to somehow use Coca-Cola's distributing success to deliver lifesaving supplies to the countries most in need. Unfortunately, the idea did not become a reality until about five years ago, with the help of Facebook and the Internet.

Once Barry's idea caught the attention of the Coca-Cola Company, the joint efforts resulted in a test program, called ColaLife. The program gets medical aid to Zambia using the extra space in Coke crates. The wedge-shaped AidPods fit in between the necks of bottles of Coca-Cola. Each AidPod, called Kit Yamoyo, or "Kit of Life," contains an anti-diarrhea kit that includes the following: a bar of soap, rehydration salts, zinc supplements, and a measuring cup.

Barry said, "Child mortality was very high, and the second biggest killer was diarrhea, which is simple to prevent." ColaLife is just one of the innovative ways in which major distributors can help save lives globally. Visit ColaLife.org to see how you can help.

[Related: Is Sevenly the Next TOMS Shoes?]

Like us on Facebook.com/TrendingNow, and follow "Trending Now" on Twitter: @Knowlesitall and @YahooTrending.

Read the rest here:

Entrepreneur Works With Coke’s Distribution to Deliver Medicine to Remote African Villages

Foundation Medicine to Present Cancer Genomic Research and Clinical Findings at the AACR Annual Meeting 2013

CAMBRIDGE, Mass.--(BUSINESS WIRE)--

Foundation Medicine, Inc., a molecular information company that brings comprehensive cancer genomic diagnostic testing and analysis to routine clinical care, today announced the companys participation in multiple sessions and presentations at the American Association for Cancer Research (AACR) Annual Meeting 2013 taking place April 6-10, 2013 in Washington, D.C.

The clinical benefit of comprehensive genomic profiling in cancer care is becoming increasingly clear as Foundation Medicine continues to present new clinical and research findings, said Vincent Miller, M.D., senior vice president, clinical development, Foundation Medicine. The collaborative studies and sessions at AACR should help advance the application of genomics and next-generation sequencing in clinical practice, and it is gratifying to see such encouraging progress.

The schedule for Foundation Medicines presentations and posters is as follows:

Date & Time: Saturday, April 6, 2013 from 10:15 to 10:40 a.m. ET Title: Clinical application of genome profiling in lung cancer Session: Future directions in personalized medicine for lung cancer Type: Educational Session Location: Room 143, Washington Convention Center Presenter: Vincent Miller, M.D., senior vice president, clinical development, Foundation Medicine

Date & Time: Sunday, April 7, 2013 from 1:00 to 5:00 p.m. ET Title: Differences in genomic alterations revealed by sequencing of 182 genes in recurrent ovarian cancer specimens compared to TCGA analysis: rearrangements in PTCH1 and FLT3; high frequency of RAS pathway alteration Abstract Number: 58 Session: Molecular Diagnostics Type: Poster Session Location: Hall A-C, Poster Section 3 Presenter: Deborah A. Zajchowski, Ph.D., scientific director, The Clearity Foundation (research in collaboration with Foundation Medicine)

Date & Time: Monday, April 8, 2013 from 1:00 to 5:00 p.m. ET Title: Identification of a novel genetic abnormality, the amplification of rictor (rapamycin-insensitive companion of mTOR), in a patient with non-small cell lung cancer Abstract Number: 2033 Session: Combination Therapies and Novel Therapeutic Approaches Type: Poster Session Location: Hall A-C, Poster Section 36 Presenter: Haiying Cheng, M.D., assistant professor, department of medicine, Albert Einstein College of Medicine of Yeshiva University (research in collaboration with Columbia University and Foundation Medicine)

Date & Time: Monday, April 8, 2013 from 1:00 to 5:00 p.m. ET Title: Next generation sequencing demonstrates multiple gene amplifications and mutations in 3 patients with estrogen receptor-positive breast cancer with responses to treatment with combination aromatase and PI3K/AKT/mTOR pathway inhibition Abstract Number: 1209 Session: Molecular Classification of Tumors Type: Poster session Location: Hall A-C, Poster Section 3 Presenter: Ralph Zinner, M.D., associate professor, Department of Investigational Cancer Therapeutics, Division of Cancer Medicine, The University of Texas MD Anderson Cancer Center (research in collaboration with Foundation Medicine)

Date & Time: Monday, April 8, 2013 from 3:00 to 5:00 p.m. ET Title: Bringing next generation sequencing (NGS) to the clinic: Analytical validation of a comprehensive NGS-based cancer gene test Abstract Number: 2279 Session: Identification of New Targets and Pathways in Cancer: Translating Basic Discoveries into the Clinic Type: Minisymposium Location: Room 207, Washington Convention Center Presenter: Roman Yelensky, director, clinical genomic analysis, Foundation Medicine

Date & Time: Tuesday, April 9, 2013 from 8:15 to 10:15 a.m. ET Session: Regulatory Considerations for Integrative Biomarker Development Using Whole Genome Technologies Type: Regulatory Science and Policy Session Location: Room 144, Washington Convention Center Presenter: Vincent Miller, M.D., senior vice president, clinical development, Foundation Medicine

Continue reading here:

Foundation Medicine to Present Cancer Genomic Research and Clinical Findings at the AACR Annual Meeting 2013

BrightScope Releases Top 25 Companies in the Health and Medicine Industry With the Best 401k Plans

SAN DIEGO, CA--(Marketwire - Mar 26, 2013) - BrightScope (www.brightscope.com), a leading provider of independent financial information and investment research, today announced the Top 25 companies with the highest ranked 401k plans containing more than $100 million in assets in the health and medicine sector. This is the third list in a new series that BrightScope will regularly issue to highlight the strongest plans within leading industries across the nation.

BrightScope obtains an increasing amount of its data directly from plan sponsors and record keepers, and augments these primary sources with data from publicly available sources such as the Department of Labor and the Securities and Exchange Commission. By analyzing and interpreting this data, BrightScope provides unprecedented transparency into the 401k industry.

"Like all important life matters, whether it's physical health or financial well-being, due diligence and research should be a priority," said Mike Alfred, CEO and co-founder of BrightScope. "That is where these lists and the BrightScope rating can help -- it gives employers and employees easy access to information about their 401k plan and provides benchmarks for creating more robust and reliable offerings."

Key statistics found on the list of health and medicine companies with the best 401k plan:

Top 25 health and medicine companies with the highest ranked 401k plan containing more than $100 million in assets:

Company - Plan Name - BrightScope Rating

1. Oregon Anesthesiology Group, P.C. - Oregon Anesthesiology Group, P.C. 401(k) Profit Sharing Plan - 92.10

2. Sutter Medical Group, Inc. - Sutter Medical Group 401(k) Profit Sharing Plan - 91.61

3. Spectrum Medical Group, P.A. - Spectrum Medical Group, P.A. 401(k) Profit Sharing Plan - 91.54

4. Anesthesia Service Medical Group, Inc. - Anesthesia Service Medical Group, Inc. 401(k) Profit Sharing Plan Trust - 91.05

Originally posted here:

BrightScope Releases Top 25 Companies in the Health and Medicine Industry With the Best 401k Plans

Food and medicine airlifts across NI – Video

Basics such as bread and milk are being distributed to residents by air while a number of PSNI and Red Cross 4x4s are distributing packages to homes where there is vehicular access.

A huge number of agencies are now involved in attempts to get the region back on its feet - NI's emergency services and mountain rescue teams are just some of those involved.

Aerial shots taken from UTV's helicopter show Co Antrim farms and roads blanketed in snow as disruption to work and travel continues.

PSNI Chief Superintendent Chris Noble said: "All the agencies are working closely together to ensure those affected by the continuing hazardous weather conditions have essential supplies such as food and medicine.

"We are all working hard to get the supplies to those in areas where vehicular access is difficult. Some of these people have now been snowed in for four days and it is vital we ensure they have adequate food and medical supplies," the District Commander said.

"While there has been an improvement in conditions in many areas, there are still hazardous conditions in a number of areas."

Chief Supt Noble appealed for motorists to only travel if absolutely necessary.

In some areas, heavy snow drifts left roads impassable, and many motorists were forced to abandon their cars.

A Met Office yellow warning for ice is in place until Tuesday morning.

"I would also appeal to walkers to be mindful of the dangers of snow covered hills and mountains. Do not place yourself in unnecessary danger," the senior police officer added.

Read the original here:

Food and medicine airlifts across NI - Video

In Twist, Fake Medicine Could Save Rare Animals

Fake and diluted ingredients, including herbs and animal parts,are increasingly finding their way into traditional Chinese medicines. Investigators have found many supposedly medicinal powders diluted with everything from flour to corn starch to sand.

Sometimes the dilutions are the result of cutting corners by manufacturers, but often its done by middlemen and retailers seeking to increase their profit margins.

PHOTOS:Most Threatened Species

There is little or no governmental regulation of these medicines, and the problem is getting worse. As one traditional Chinese medicine manufacturer noted, counterfeiters are posing a great threat, as fake products are made to closely resemble genuine ones.

Counterfeiters can produce fake medicinal herbs with starch and gypsum powder, or mix dirt or dust with the herbs to increase their weight.

Dilution, Inert Ingredients and Placebos

Many legitimate, regulated drugs and food products contain inert or inactive ingredients or fillers. Sometimes these ingredients help delay or speed up the bodys absorption of a drugs active ingredient, for example, while fillers in food may add flavor or bulk, coloring or increase shelf life.

While some Chinese herbs and medicines have active ingredients and work as promised, many others do not, and their efficacy relies on the placebo effect. Because the placebo effect works when the patient believes a drug or treatment is effective, there are relatively few complaints from consumers themselves. The effectiveness is often the same whether the medicines are real, diluted or fake.

This is not to say that altered, diluted, or fake medicine of any kind is good, of course. Though most of the ingredients used to dilute drugs are relatively harmless, some can be toxic. In some cases Chinese herbal medicines may even be contaminated with prescription medications.

A 2002 study in The Journal of Internal Medicine reported that an analysis of 2,600 samples of Chinese herbal remedies in Taiwan showed that 24 percent were adulterated with at least one synthetic medicine. The case reports showed that two or more adulterants were present in 14 of 15 Chinese herbal medicines.

See the original post:

In Twist, Fake Medicine Could Save Rare Animals

Reality show drive-by: Married to Medicine

Meet two perfectly nice and accomplished female doctors... and a clique of materialistic reality TV crazies

Bravo's newest offering, Married to Medicine, may not be worth watching week in and week out. But it is worth taking a few moments to mull over... at least after the glittery gem-toned enamel that Sunday's premiere was coated in stops blinding your eyes.

As bizarre as the longevity of this trend might seem, we're still in a white-hot cultural moment for shows about glamorous women enjoying lives of luxury thanks to their successful husbands. (See: The Real Housewives franchise, Basketball Wives, Love & Hip Hop, etc.) The grueling year-round schedule of Housewivesin particularkeeps Bravo viewers tethered to their TVs as the cameras hop from gaggles of shiny-haired women in Atlanta to New York to Miami to New Jersey to Orange County to Beverly Hills and back again. So it's little surprise that Andy Cohen and his Bravo minions would seek a way to tap further into this zeitgeist while angling for a new and interesting twist. Enter Married to Medicine's group of female black doctors and wives, both white and black, of doctors.

SEE MORE: Was the Iraq War a huge coup for liberalism?

Wait, what?

Black female doctors don't seem like the obvious target for a network like Bravo, which trades primarily in fake-tanned, forty-something women yanking out each others' hair extensions and throwing glasses of chardonnay at poolside gatherings. And that's exactly why the announcement of Married to Medicine triggered some upset, particularly in the black medical community. Students at Howard University even went so far as to set up a petition on Change.org asking the network to cancel the program "for the sake of integrity and character of black female physicians." As they point out in the petition, commercials for the show look to associate "black females in medicine with materialism, "cat fights," and unprofessionalism."

SEE MORE: Will the GOP nominee support gay marriage in 2016?

Clearly, the petition went unnoticed by Bravo. And if last night's premiere episode of Married to Medicine is any indication, cat fights and unprofessionalismare the name of the game with this group which includes relatively few actual black female doctors.

The series opens with a birthday party at self-described "Queen Bee" Mariah's house, where we meet fellow cast members Toya, Kari, and the all-out lunatic of the bunch, Quad. None of them are doctors. Instead, their husbands are successful doctors. And it appears from their bios that their time is filled managing their households, doing charity work, and planning parties.Remember, after all, that this is a Bravo show, so the majority of interactions (read: fights) between the women need to take place at each other's events (read: shoe launch party, child's birthday party, etc.). Meanwhile, the two actual female doctors of the group, Dr. Simone Whitford and Dr. Jackie Walters (both OB/GYNs), come across as levelheaded and self-aware. In other words, they could not seem more out of place.

SEE MORE: Susan Spencer-Wendel's 6 favorite books

Original post:

Reality show drive-by: Married to Medicine